Regulation of progesterone receptor (PR) in uterine stroma (endometrial stroma plus myometrium) by estrogen was investigated in estrogen receptor-␣ (ER␣) knockout (␣ERKO) mice. 17␤-Estradiol (E 2 ) increased PR levels in uterine stroma of ovariectomized ␣ERKO mice, and ICI 182 780 (ICI) inhibited this E 2 -induced PR expression. Estrogen receptor-␤ (ER␤) was detected in both uterine epithelium and stroma of wild-type and ␣ERKO mice by immunohistochemistry. In organ cultures of ␣ERKO uterus, both E 2 and diethylstilbestrol induced stromal PR, and ICI inhibited this induction. These findings suggest that estrogen induces stromal PR via ER␤ in ␣ERKO uterus. However, this process is not mediated exclusively by ER␤, because in ER␤ knockout mice, which express ER␣, PR was up-regulated by E 2 in uterine stroma. In both wild-type and ␣ERKO mice, progesterone and mechanical traumatization were essential and sufficient to induce decidual cells, even though E 2 and ER␣ were also required for increase in uterine weight. Progesterone receptor was strongly expressed in decidual cells in ␣ERKO mice, and ICI did not inhibit decidualization or PR expression. This study suggests that up-regulation of PR in endometrial stroma is mediated through at least three mechanisms: 1) classical estrogen signaling through ER␣, 2) estrogen signaling through ER␤, and 3) as a result of mechanical stimulation plus progesterone, which induces stromal cells to differentiate into decidual cells. Each of these pathways can function independently of the others. decidua, estradiol, progesterone receptor, uterus
INTRODUCTION
Progesterone (P 4 ) is a key coordinator of female reproduction, and in female mammals, P 4 directly regulates many functions, such as sexual behavior [1] , ovulation [2] , uterine growth [3] , implantation [4] , and mammary gland development [5, 6] . Most actions of P 4 are mediated via progesterone receptor (PR). Hence, female mice null for PR (PR knockout) are infertile and exhibit impaired secondary sexual development [7] . Progesterone receptor is a member of the steroid-retinoid receptor superfamily and functions as a P 4 -modulated transcription factor [8] . In the most species, including human and mouse, PR is composed of two major ligand-binding forms (the long B form and a N-terminal truncated A form) encoded by one gene [9] . Progesterone receptor is one of most well-studied estrogen-regulated genes and is widely recognized as a marker for estrogen action [10] . Regulation of the PR gene by estrogen has been extensively studied. Within the PR gene promoter, clusters of estrogen response element (ERE) half-sites are present, which are essential for transactivation of the PR gene by liganded estrogen receptor (ER) [11] [12] [13] . Because the PR protein level is thought to be a critical determinant of sensitivity to P 4 , almost all hormone treatment protocols designed to elicit effects of P 4 usually involve previous estrogen priming to induce PR.
Estrogen actions are mediated by ER␣ and/or ER␤, the two forms of ER, which have been identified in many species, including rat, human, and mouse [14] [15] [16] . The amino acid sequences of ER␣ and ER␤ in these three species are highly homologous in the DNA-binding domain and moderately homologous in the ligand-binding domain. Both ER␣ and ER␤ can bind 17␤-estradiol (E 2 ) and transactivate genes that are regulated through ERE [17, 18] . Expression of ER␣ in the mouse uterus has been well documented [19] , and ER␤ mRNA has also been detected in wild-type and ER␣ knockout (␣ERKO) uteri [20] . Similarly, ER␤ mRNA and protein have been detected in the rat uterus [21] [22] [23] [24] [25] , and ER␤ mRNA has been detected in the human uterus [26] . However, the ER␤ level in uterus is generally low compared to that of granulosa cells in ovary, where a very high level of ER␤ is detected [22] [23] [24] [27] [28] [29] . Moreover, in the uterus of ␣ERKO mice, estrogen did not increase known markers of estrogen action, such as DNA synthesis, or transcription of the lactoferrin and glucose-6-phosphate dehydrogenase genes, despite the presence of ER␤ [30, 31] . In contrast, the uterus of ER␤ knockout (␤ERKO) mice appears to be normal [27] . These studies suggest that ER␣ is the major receptor mediating E 2 action in the mouse uterus, and that ER␤ may not have unique functions in the rodent uterus. In a previous study, we observed that PR is up-regulated by E 2 in the uterine stroma of ␣ERKO mice [32] . In the current study, regulation of PR by estrogen in uterine endometrial stroma and myometrium of ␣ERKO mice was studied in greater depth.
Both P 4 and E 2 are essential for establishment and maintenance of pregnancy. Whereas P 4 is required throughout pregnancy, E 2 is essential only during early pregnancy, especially around the time of implantation. In rodents, E 2 is essential in addition to P 4 to ready the uterus for implan-tation of the blastocyst [33] . No obvious morphological changes occur in endometrial stroma before implantation, but contact with the blastocyst is an essential stimulus to induce decidualization of endometrial stroma cells [34] . The importance of P 4 and PR is well established, but the roles of E 2 and ERs in implantation and decidualization are not clear. Decidualization can be induced artificially by a combination of P 4 -treatment and a mechanical traumatization of the uterine horn in the absence of estrogen [35] . Implantation of transferred blastocysts can occur without priming ovariectomized mice with E 2 [36] . Recent studies have shown that decidualization occurs in ␣ERKO mice; thus, classical estrogen actions through ER␣ are not required for decidualization [37, 38] . On the other hand, E 2 is required for natural decidualization during normal pregnancy or artificial decidualization induced by mild stimuli such as intrauterine oil injection [39] . The continued presence of E 2 reduces the dosage of P 4 required to maintain pregnancy after implantation, and E 2 deficiency can be overcome by high doses of P 4 [40] . These facts suggest that E 2 action through ER␣ itself does not generate signals that are essential for implantation and decidualization but, instead, modifies the sensitivity of uterine cells to the effects of P 4 , perhaps by regulating PR level. For these reasons, we studied the effects of E 2 and P 4 on PR expression in endometrial stroma of ␣ERKO mice during decidualization.
MATERIALS AND METHODS

Animals and Treatments
All animals were maintained in accordance with the National Institutes of Health Guide for Care and Use of Laboratory Animals, and all procedures described here were approved by the University of California-San Francisco and University of Illinois animal care and usage committees. Mice were maintained under controlled temperature and lighting conditions during the experiment and were given food (Purina Laboratory Chow; Ralston Purina Company, St. Louis, MO) and water ad libitum. The ␣ERKO [30] and ␤ERKO mice [27] , with a C57BL6J/129Svj mixed genetic background, were produced as described previously. Adult female athymic nude mice were purchased from Charles River (Wilmington, MA).
To test the effect of E 2 on PR expression, all animals were ovariectomized at least 2 wk before hormone treatment. Small pieces of uterus were collected with ovary at the time of ovariectomy. These uterine tissue samples were used as uteri from intact mice. Ovaries were used as positive control for ER␤ staining. Daily dosages of 125 ng of E 2 (Sigma, St. Louis, MO), with or without 50 g of ICI 182 780 (ICI; Zeneca, Cheshire, UK), were injected i.p. in 0.1 ml of peanut oil (Sigma). Ovariectomized adult (60-80 days old) female wild-type, ␣ERKO, ␤ERKO, and host athymic mice bearing grafts of ␣ERKO uterine tissues received oil, E 2 , or E 2 plus ICI for 3 days. Twenty-four hours after the last hormone injection, animals were sacrificed to harvest tissue samples. To study the effect of E 2 on uteri of ␣ERKO and wild-type mice under identical endocrine conditions, portions of uteri from mature adult ␣ERKO and wild-type mice were surgically isolated and grafted under the contralateral renal capsules of female athymic nude mice. Approximately 1 mo after grafting, all hosts were ovariectomized and then received hormone treatments described above.
For artificial decidualization, hormone treatment was given as described previously [41] . The ␣ERKO and wildtype mice were ovariectomized at least 2 wk before the hormone treatments. All hormones were injected i.p. in 0.1 ml of peanut oil (Sigma) to give the following groups: 1) oil-treated group, oil on Days 1-3 and 6-12; 2) P 4 -treated group, oil on Days 1-3 and 500 g/day of P 4 on Days 6-12; 3) E 2 ϩP 4 -treated group, 100 ng/day of E 2 on Days 1-3 and 500 g/day of P 4 plus 10 ng/day of E 2 on Days 6-12; and 4) ICIϩP 4 -treated group, 50 g/day of ICI on Days 1-3 and 500 g/day of P 4 plus 50 g/day of ICI on Days 6-12. On Day 9, the body cavity was opened and the right uterine horn scratched from the inside with a needle tip at 6 h after the last hormone treatment (traumatization). On Day 13, animals were killed, and the wet weight and length of the uterine horns were measured.
Preparation of Total RNA
The procedure for RNA preparation has been described previously [32, 42] . Adult female ␣ERKO mice were ovariectomized. Two weeks later, mice were given three daily treatments with oil or E 2 as described above. All mice were killed 24 h after the last injection, and uteri were removed. Epithelium and stroma were isolated as described previously [43] and then flash-frozen in liquid nitrogen. Uteri from three mice were used for each treatment group. The experiment was repeated three times. Total RNA was prepared from frozen uterine stromal tissue using the RNeasy Mini Kit (Qiagen, Chatsworth, CA). Purity and concentration of the RNA were determined by ultraviolet (UV; 260/ 280 nm) absorbance using a spectrophotometer.
Northern Blotting
For all Northern blots used, equal amounts of RNA from control (oil-treated) and E 2 -treated mice were electrophoresed on a 1.5% v:v agarose formaldehyde gel. The gel was blotted to nylon membranes, and the RNA was fixed to the membrane by UV cross-linking. Murine PR cDNA [44] was a gift from Dr. G. Shyamala (Lawrence Berkeley Laboratory, Berkeley, CA). Human 28S rRNA [45] was used for a loading control. The PR cDNA probe was labeled with 32 P-deoxycytidine triphosphate using the multiprime DNAlabeling system (Amersham, Arlington Heights, IL) and hybridized at 68ЊC. The hybridized membrane was washed and exposed to Kodak X-omat x-ray film (Kodak, Rochester, NY) with intensifying screens. After hybridization with the PR cDNA probe, membranes were stripped of probe and then reprobed with the 28S rRNA cDNA probe as described previously [46] .
Immunohistochemistry
Anti-human PR rabbit polyclonal immunoglobulin (Ig) G (Dako, Carpenteria, CA) and anti-human-ER␣ mouse monoclonal IgG 1D5 (Dako) were used at 1:100 and 1:50 dilutions (v:v), respectively. Alkaline phosphatase-conjugated, anti-smooth muscle actin mouse monoclonal IgG (Sigma) was used at a 1:1000 dilution (v:v). Anti-human-ER␤ chicken polyclonal antibody (ER␤ 503 IgY) [47] was used at a 1:600 dilution (v:v). Anti-human-ER␤ sheep polyclonal antibody was generated against a peptide directed against the hinge (D) domain of human ER␤ (CAG-KAKRSGGHAPRVREL; Affinity Reagents, Exeter, UK) as described previously [48] . Briefly, the peptide was conjugated via cysteine residue to keyhole limpet hemocyanin and injected into a sheep; immunization and recovery of antisera were all carried out by Diagnostic Scotland Car- luke (Lanarkshire, UK). Antisera were fractionated by sodium acetate precipitation, and the supernatant was dialyzed against PBS (pH 7.4) and applied to affinity peptide columns. The specificity of this antibody has been studied by Western blotting [48] . This antibody was used for immunohistochemistry at a 1:1000 dilution (v:v).
Tissues were fixed with 4% paraformaldehyde for 3 h on ice, processed into paraffin, and then sectioned at 6 m. Slides were heated in 10 mM citrate buffer solution (pH 6.0) by microwave or pressure cooker. Immunohistochemical detection of ER␣ [32] , ER␤ [22] , and PR [49] by the horseradish peroxidase-avidin biotin complex method has been described previously. Immunoreactivity for ER␣, ER␤, and PR was visualized utilizing 3,3Ј-diaminobenzidine tetrahydrochloride (DAB; Sigma). The immunoreactivity for smooth muscle actin was developed by the VectorRed alkaline phosphatase staining kit (Vector Laboratories, Burlingame, CA). Specificity of ER␤ immunohistochemistry in the mouse uterus was checked using antihuman-ER␤ sheep IgG preabsorbed with immobilized peptide corresponding to the hinge (D) domain of human ER␤. To test the specificity, ovary and uterus of wild-type and ␣ERKO mice were stained with ER␤ 503 IgY antibody preabsorbed with human recombinant ER␤ (PanVera Corporation, Madison, WI).
Image Analysis
To determine the percentage of PR-positive endometrial stromal cells, images of PR immunohistochemistry were captured with a DC330 camera (Dage-MTI, Michigan City, IN) interfaced with a PowerBase 200 computer (Power Computing, Round Rock, TX) and analyzed with Scion Image 1.62a (Scion, Frederick, MD) software. All images were captured in CMYK (cyan, magenta, yellow, and black) mode under the exact same lighting conditions. In the combination of cyan and magenta channels (CϩM channel), nuclei of PR-positive cells (stained brown from DAB) and negative cells (stained blue from hematoxylin) were equally detected. In the combination of yellow and black channels (YϩK channel), only nuclei of PR-positive cells were detected. Nuclei of all endometrial stromal cells were manually selected by adjusting the threshold for optical density (OD) in the CϩM channel. Total selected area (i.e., total nuclear area) and area with an OD higher than the average OD of the negative control in the YϩK channel (i.e., PR-positive nuclear area) were measured. The percentage of PR-positive endometrial stromal cells was calculated as (PR-positive nuclear area)/(total nuclear area) ϫ 100. In each group, the nuclear area equivalent to approximately 3000 nuclei in 6 to 10 pieces of uteri from three to five ␣ERKO mice was analyzed. To determine the average intensity of PR staining, OD in the YϩK channel was measured in the total nuclear area of untraumatized uterine horns or in the manually selected nuclear area for decidual cells. The average OD of nonimmune IgG control was used as the baseline (OD ϭ 0). In each group, an area equivalent to at least approximately 1000 nuclei in four to six pieces of uteri from two to four ␣ERKO mice was analyzed. Statistical analysis was performed using the statistical analysis package StatView (Abacus Concepts, Berkeley, CA). To compare OD between hormone treatments, factorial ANOVA was used for overall analysis, and Fisher's protected least-significant-difference (PLSD) test was used for follow-up analysis to determine the difference between groups (P Ͻ 0.05).
FIG. 2.
Northern blot analysis of PR mRNA in uterine stroma and epithelium of ␣ERKO mice. Ovariectomized female ␣ERKO mice (n ϭ 3/ group) received E 2 or oil only from Day 1 to 3. Twenty-four hours after the last hormone injection, animals were killed to harvest tissue samples. The E 2 increased PR mRNA expression in uterine stroma but did not affect PR mRNA expression in the epithelium. Loading, as determined by the intensity of a 28S rRNA hybridization signal, was similar between lanes for oil and E 2 -treated groups.
Organ Culture
Mature ␣ERKO mice (7 to 8 wk old) were ovariectomized, and 2 to 3 wk after ovariectomy, uteri were dissected and cut into small pieces (10-20 pieces/uterine horn) in a 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium (DME/F-12 medium; Gibco, Gaithersburg, NY). Uterine tissue pieces were embedded in an 1:4 mixture of growth factor-reduced Matrigel (Becton Dickinson Labware, Bedford, MA) and rat-tail collagen gel and then cultured in DME/F-12 medium containing 10% fetal calf serum overnight. The medium was then changed to DME/F-12 medium with transferrin (5 g/ml; Sigma) and insulin (10 g/ml; Sigma). After 2 days of cultivation, the medium was changed to DME/F-12 containing 10 Ϫ6 M ICI and/or 10 Ϫ8 M E 2 or diethylstilbestrol (DES; Sigma). After four additional days of cultivation, uterine cultures were fixed as described above. To quantitate PR level in endometrial stromal cells, the morphometric analysis was performed on slides immunostained for PR as described above. A one-tailed statistical test was used to verify if estrogens (E 2 and DES) could increase PR-positive cells in endometrial stroma in organ culture. Use of a one-tailed statistical test is appropriate when a directional, a priori hypothesis is specified [50] .
RESULTS
Expression of PR Induced by E 2 in Uterine Stroma of ␣ERKO Mice In Vivo
Expression of PR was assessed by immunohistochemistry in the uterus of ␣ERKO mice. In uteri of these mice, PR staining was strong in the luminal epithelium and the subepithelial endometrial stroma (Fig. 1a) and was weak or undetectable in the peripheral endometrial stroma and myometrium (Fig. 1b) . In ␣ERKO mice treated for 3 days with oil 14 days after ovariectomy (OVX), the PR level was dramatically reduced in the endometrial stroma (Fig. 1c) , but epithelial PR staining remained intense. Whereas PR expression in uterine epithelium did not change with E 2 treatment in ␣ERKO mice, three injections of 125 ng of E 2 induced strong PR expression in the endometrial stroma (Fig. 1, c and e) . Similarly, E 2 induced PR in the myometrium of ␣ERKO mice (Fig. 1, d and f) . Up-regulation of PR by E 2 in uterine endometrial stroma and myometrium was completely inhibited by coadministration of ICI (Fig.  1, g and h) .
The PR mRNA level was analyzed in isolated uterine epithelium and stroma (i.e., endometrial stroma plus myometrium) to confirm results in the immunohistochemical study. A representative Northern blot is demonstrated in Figure 2 . Northern analysis showed induction of PR mRNA by E 2 in stroma of ovariectomized ␣ERKO mice (Fig. 2 , UtS), whereas in uterine epithelium, the PR mRNA level remained high in oil-and E 2 -treated, ovariectomized ␣-ERKO mice (Fig. 2, UtE) . The PR mRNA level in uterine stroma was extremely low compared to that of the epithelium in both oil-and E 2 -treated groups. This suggests that the increase in the level of stromal PR mRNA induced by estrogen can be masked by constitutive expression of epithelial PR mRNA in an analysis of whole-uterine extract.
The PR immunohistochemistry was quantitated via image analysis by measuring the percentage of PR-positive endometrial stromal cells (Fig. 3) . Differences in the percentage of PR-positive stromal cells between all four groups (intact, OVXϩoil, OVXϩE 2 , and OVXϩE 2 ϩICI) were all significant (P Ͻ 0.05). Values ranged from highest to lowest in the following order: OVXϩE 2 Ͼ intact Ͼ OVXϩoil Ͼ OVXϩE 2 ϩICI (Fig. 3A) . The percentage of PR-positive cells in endometrial stroma decreased significantly 2 wk after ovariectomy, and E 2 -treatment increased the PR-positive population (Fig. 3A) . However, ICI inhibited the E 2 -induced up-regulation of PR in endometrial stroma. The percentage of PR-positive endometrial stromal cells was significantly lower in the ICIϩE 2 -treated group than in the oil-treated group. This suggests residual estrogenic activity (perhaps of adrenal origin) in the uterus even 2 wk after ovariectomy.
To eliminate the possible effect of abnormal systemic hormone levels in ␣ERKO mice, E 2 effects on PR expression were studied in uteri of ␣ERKO and wild-type mice grafted contralaterally under the renal capsules of female athymic nude mice. For this purpose, ␣ERKO and wildtype uterine samples were grown for 1 mo in intact female athymic nude mice, which were then ovariectomized. Two weeks after ovariectomy, the hosts were treated with oil or E 2 as described. Induction of uterine stromal PR by E 2 in uterine grafts was identical to that observed in ␣ERKO and wild-type animals treated directly (data not shown). The percentage of PR-positive cells in endometrial stroma of ␣ERKO uterine grafts was significantly higher in E 2 -treated hosts than in oil-treated hosts (Fig. 3B) .
Expression of PR Induced by E 2 in Uterine Stroma of ␣ERKO Mice In Vitro
To test whether E 2 induces PR via direct action on uterus or via other systemic endocrine effects, uteri from ovariectomized ␣ERKO mice were placed in organ culture. To assess PR expression in myometrium, explants were double-stained for PR (brown) and smooth muscle actin (red).
In organ culture without hormonal supplementation, PR was down-regulated in uterine epithelium, which had been strongly positive for PR in the absence of estrogen in vivo. The endometrial stroma, which had been very weakly positive in vivo (Fig. 1c) , became positive for PR without es- trogen treatment (Fig. 4a) . Both E 2 and DES increased the PR-positive cell population in the endometrial stroma significantly (P Ͻ 0.05; Figs. 4c and 5). In the absence of estrogen, ␣ERKO myometrium was mostly negative for PR (Fig. 4b) . Both DES and E 2 induced PR expression in myometrial cells (Fig. 4d) . Thus, estrogens induce PR in endometrial stroma and myometrium of ␣ERKO mice through direct action on uterine cells.
To assess whether estrogens induce PR in uterine stroma via ER, effects of ICI on PR expression were studied in ␣ERKO uterine organ cultures. We found that ICI inhibited estrogen-induced PR expression in myometrium and endometrial stroma (Figs. 4, e and f, and 5) . These results suggest that estrogen induces PR in endometrial stroma and myometrium of ␣ERKO mice through ER␤ or another unidentified pathway whose function is blocked by ICI.
Localization of ER␤ in Mouse Uterus
Localization of ER␤ in wild-type and ␣ERKO uterus was studied by immunohistochemistry. Mouse monoclonal anti-ER␣ IgG 1D5 stained uterine tissues from wild-type (Fig. 6a) but not ␣ERKO (Fig. 6b) mice. In contrast, antihuman-ER␤ sheep polyclonal antibody stained uterine tissues of both wild-type (Fig. 6c) and ␣ERKO mice (Fig.  6d) . In the uterus of both wild-type and ␣ERKO mice, localization of ER␤ was very similar to that of ER␣ in wildtype mice and, thus, was detected in the nuclei of endometrial stroma, myometrium, luminal, and glandular epithelia. In both oil-and E 2 -treated ␣ERKO mice, ER␤ protein was detected in endometrial stroma and myometrium, in which PR was also detected in E 2 -treated ␣ERKO mice (Figs. 1e and 6d ). Ovaries were used as a positive control, because granulosa cells in the ovary express a high level of ER␤ [22-24, 27, 28] . In both wild-type (data not shown) and ␣ERKO (Fig. 6h) mice, nuclei of granulosa, theca, and interstitial cells were stained with this anti-human-ER␤ sheep polyclonal antibody (Fig. 6h) . In the negative controls with the peptide-absorbed primary antibody, ER␤ signal was completely absent in the ovary (data not shown) and uterus (Fig. 6g) . Localization of ER␤ protein was confirmed with another anti-ER␤ chicken antibody, ER␤ 503 IgY [47] . In both wild-type (Fig. 6e) and ␣ERKO (Fig. 6f) uteri, the immunostaining pattern obtained with ER␤ 503 IgY was essentially identical to that obtained with the antihuman-ER␤ sheep polyclonal antibody. Preabsorption with human recombinant ER␤ completely abolished the positive nuclear signal from uterus and ovary of both wild-type and ␣ERKO mice (data not shown).
Expression of PR Inducted by E 2 in Uterine Stroma of ␤ERKO Mice In Vivo
Because ER␤ appears to mediate E 2 up-regulation of uterine stromal PR, E 2 regulation of uterine stromal PR was compared in wild-type and ␤ERKO mice, which both express ER␣ ( Fig. 6, a and d) . In the uterus of both wild-type and ␤ERKO mice, intensity of PR signal and number of PR-positive cells in the endometrial stroma and myometrium were low in ovariectomized oil-treated mice (Fig. 6, b and e) but high in E 2 -treated mice (Fig. 6, c and f) . Thus, ER␤ is not essential for up-regulation of uterine stromal PR by E 2 . The PR level in uterine epithelium is high in the absence of E 2 and down-regulated by E 2 via stromal ER␣ [32] . Thus, down-regulation of epithelial PR by E 2 did not occur in ␣ERKO uterus (Fig. 1) . In contrast to ␣ERKO mice [32] , uterine epithelial PR was down-regulated by E 2 in wild-type and ␤ERKO mice (Fig. 6, b, c, e, and f) . Overall, the effect of ovariectomy and E 2 -treatment was identical in the uteri of ␤ERKO mice and wild-type mice. Thus, our observations confirm the idea that ER␣ is the major mediator of estrogen action in the mouse female reproductive tract.
Decidualization in Wild-Type and ERKO Mice
Because PR expression in uterine stroma is induced by E 2 in ␣ERKO mice, we determined whether E 2 modifies the action of P 4 to induce decidualization via an ER␣-independent pathway. Mature female wild-type and ␣ERKO mice were ovariectomized and, 2 wk later, received hormone treatment.
Uterine weight. In wild-type mice, wet weight of the untraumatized uterine horn was significantly higher in the E 2 ϩP 4 -treated group than in the oil-and P 4 -treated groups. In contrast, in ␣ERKO mice, no significant difference was found in the wet weight of untraumatized uterine horn among all groups (oil, P 4 , E 2 ϩP 4 , and ICIϩP 4 ) (Fig. 7,  ␣ERKO) . Thus, E 2 increases the wet weight of untraumatized uterine horns via an ER␣-dependent pathway. In both wild-type and ␣ERKO mice, P 4 treatment plus traumatization increased the wet weight of the uterine horn significantly compared to oil treatment plus traumatization or to P 4 treatment alone. In wild-type mice, the traumatized uterine horn was significantly heavier in the E 2 ϩP 4 -treated group than in P 4 -and oil-treated groups (Fig. 7, WT) . In contrast, E 2 did not synergize P 4 action to increase the wet weight of traumatized uterine horn in ␣ERKO mice (Fig.  7, ␣ERKO) . In ␣ERKO mice, no significant difference was found in the wet weights of traumatized uterine horns between the ICIϩP 4 -treated group and the P 4 -or E 2 ϩP 4 -treated groups (Fig. 7, ␣ERKO) . Because pretreatment plus coadministration of ICI with P 4 did not inhibit the increase in wet weight of traumatized uterine horns, actions of residual estrogen in the body are not involved in the increased wet weight of traumatized uterine horns in ovariectomized c, d, h, and g) , and anti-human-ER␤ chicken polyclonal antibody ER␤ 503Y (e and f) were used. As a negative control (g), anti-human-ER␤ rabbit polyclonal antibody was preabsorbed with specific ER␤ peptide (CAGKAKRSGGHAPRVREL). Ovary of ␣ERKO mice (h) was shown as a positive control for ER␤. ep, Epithelium; st, endometrial stroma; myo, myometrium. Bar ϭ 50 m (a-g) or 100 m (h).
FIG. 6.
Estrogen receptor-␣ and PR immunohistochemistry in the uterus of wild-type and ␤ERKO mice. Adult female wild-type and ␤ERKO mice (60 days old) were ovariectomized. Ovariectomized wild-type (a-c) and ␤ERKO mice (d-f) were treated with oil or 125 ng of E 2 for 3 days. Tissues were processed as described in Materials and Methods and then stained for ER␣ (a and d) and PR (b, c, e, and f). Expression of PR is essentially identical in the uterus of wild-type and ␤ERKO mice. Representative images of two independent experiments are shown. Total number of animals used was three for each group (E 2 -or oil-treated wild-type or ␤ERKO). ep, Epithelium; st, endometrial stroma; myo, myometrium.
FIG. 7.
Wet weight of uterine horns in the decidualization experiment. To induce decidualization, wild-type (WT) and ␣ERKO mice were ovariectomized at least 2 wk before hormone treatments. Daily doses of 100 ng of E 2 (E 2 ϩP 4 -treated group) or 50 g of ICI (ICIϩP 4 -treated group) in 0.1 ml of peanut oil, or 0.1 ml of peanut oil only (oil-and P 4 -treated groups), were injected on Days 1-3. On Days 6-12, animals received 500 g of P 4 plus 10 ng of E 2 per day (E 2 ϩP 4 -treated group), 500 g of P 4 plus 50 g of ICI per day (ICIϩP 4 -treated group), 500 g of P 4 per day (P 4 -treated group), or 0.1 ml of peanut oil per day (oil-treated group). On Day 9, the body cavity was opened, and the right uterine horn was scratched (traumatized) from the inside with a jagged-tip needle 6 h after the last hormone treatment. The left uterine horn was not traumatized as a control (untraumatized). On Day 13, animals were killed, and the wet weight and length of the uterine horns were measured. Wet weight was determined as weight (g)/length (cm). Data are presented as mean Ϯ SEM. All data were statistically analyzed by factorial ANOVA and Fisher's PLSD tests. The mean value was significantly different in all groups indicated by different letters (a-d) . The mean values of each groups are in the following order: a Ͻ b Ͻ c Ͻ d.
␣ERKO mice. In comparing wild-type and ␣ERKO mice, the weight of traumatized uterine horn in P 4 -treated wildtype mice was statistically identical to that of P 4 -, E 2 ϩP 4 -, and ICIϩP 4 -treated ␣ERKO mice. These data suggest that during decidualization, P 4 and traumatization are essential to increase the wet weight of uterine horns, but that E 2 signal via ER␣ also has a synergistic effect on the wet weight of uterine horns. In conclusion, ER␣-independent estrogen action in ␣ERKO uterus does not modify the wet weight of uterine horns, even though estrogen induces PR in endometrial stroma of ␣ERKO mice.
Decidual cell differentiation and PR expression. In both ␣ERKO and wild-type mice, decidual cells were never detected in untraumatized uterine horns of all groups (Fig. 8,  a-e) . Likewise, decidual cells were not observed in traumatized uterine horns of the oil-treated group (Fig. 8g) . In contrast, decidual cells were observed in all other groups receiving P 4 -treatment and traumatization (Fig. 8) . Thus, both P 4 -treatment and traumatization were essential and sufficient for differentiation of uterine stroma to decidual cells in both wild-type and ␣ERKO mice (Fig. 8) .
The histology of artificially induced decidual cells in ␣ERKO mice (Fig. 8, h-j) was comparable to that of wildtype mice (Fig. 8f) . In the decidual cells, PR was strongly expressed irrespective of the hormone treatment (P 4 , E 2 ϩP 4 , or ICIϩP 4 ) (Fig. 8, h-j) . In ␣ERKO mice, ICI at a dosage of 50 g/mouse per day did not inhibit decidualization or induction of high levels of PR expression in decidual cells (Fig. 8, g and h) . These data suggest that the high level of PR resulted from decidual differentiation requiring P 4 treatment and traumatization but not E 2 and ERs. Although decidual differentiation was never detected, the P 4 -treatment (Fig. 8, c-e) or traumatization (Fig. 8g) alone slightly increased PR in endometrial stroma (Fig. 9) . However, the level of PR induced by P 4 without traumatization or by traumatization alone was minimal and, thus, not comparable to that induced by E 2 ϩP 4 without traumatization or decidualization (P 4 ϩtraumatization) (Fig. 9) . The PR level in endometrial stroma appeared to increase slightly in untraumatized uterine horns of oil-treated mice (Fig. 8b) compared to those in oil-treated ovariectomized mice (Fig. 1a) . The difference in treatments of these two groups is the presence or absence of mechanical stimulation to the other uterine horn. This suggests that mechanical stimulation increases PR in endometrial stroma, at least partially, via a systemic effect.
DISCUSSION
In this study, we have shown that estrogen can induce PR expression in endometrial stroma and myometrium through ER␣-independent pathways. Recently, Curtis et al. [38] reported that PR is not up-regulated by E 2 in ␣ERKO uterus, even though the R5020-binding level in whole-uterine homogenates decreased after ovariectomy. In their study, PR levels were assessed in whole uteri. The uterus is composed of three major tissue types (i.e., epithelium, endometrial stroma, and myometrium), and the total PR level in whole uterus is the average of the PR levels in all tissue types. Thus, measurement of mRNA or proteins in whole uterus is affected by the individual PR level in each cell type and the relative abundance of each cell type in the uterus. In this regard, McCormick and Glasser [51] have demonstrated that in whole-uterine homogenates, changes in estrogen-binding activity in uterine epithelium is masked by changes in myometrium because the myometrium is the most abundant tissue, even though epithelium contains the highest concentration of estrogen-binding activity on a percell basis among the three tissue components of the uterus. Because PR is differentially regulated in the three tissue compartments by E 2 , either directly via ER␣ in the responding cell type or indirectly via paracrine mechanisms [32] , changes in protein, mRNA, or hormone-binding levels must be studied in each isolated tissue type to gain biologically meaningful data. Analysis of whole-uterine homogenates can be misleading in regard to gene regulation at the tissue and cellular levels.
A null mutation in a key element of hormone action, such as ER␣ and PR, often alters the entire systemic endocrine profile [52, 53] . For this reason, hormonal levels in intact ␣ERKO and wild-type mice differ substantially, and thus, ␣ERKO and wild-type uteri of intact females are exposed to vastly different hormone levels. Grafting two different groups of hormone target organs to contralateral renal capsules of athymic hosts eliminates such hormonal differences so that mutant and wild-type organs can be studied under identical hormonal conditions. In this study, regulation of PR by E 2 in ␣ERKO uterine grafts was identical as in the experiments using animals directly.
When a hormonal effect is observed in an organ, the effect may be mediated directly through receptors in the organ or indirectly through receptors in other target organs that may affect systemic hormones. Organ culture was utilized to assess whether estrogen action on the uterine stroma of ␣ERKO mice is direct or indirect. Although in organ culture PR expression was not exactly identical to that in vivo, up-regulation of stromal/myometrial PR in uterine explants grown in vitro confirmed that the signaling pathways within the uterus of ␣ERKO mice can mediate the effect of estrogen to up-regulate PR in the uterine stroma/myometrium. The reason why uterine cells express PR differentially in vivo and in vitro is not clear.
The discrepancy between PR expression and regulation in vivo versus in vitro, though not fully understood, is a potentially serious problem for the field. As demonstrated recently by several groups, administration of E 2 to ovariectomized mice dramatically down-regulates PR in mouse uterine epithelium, and the effect is mediated via stromal ER␣ [32] . In contrast, when mouse uterine epithelial cells are cultured by themselves in vitro, E 2 up-regulates PR [54] . Likewise, the PR profile in the mouse uterine organ cultures is slightly different from that in vivo as reported herein. Clearly, it is the in vivo observations to which all other artificial conditions must be compared. A potential explanation that may reconcile our in vitro and in vivo observations may involve the insulin pathway. Insulin-like growth factor-I can up-regulate PR in endometrial stromal cells in vitro [55] . The medium used for the organ culture contained a relatively high level of insulin (10 g/ml), which may activate expression of PR in endometrial stroma. Also, extracellular matrix contains undefined substances, and a molecule in the extracellular matrix may induce PR in endometrial stroma. Uterine epithelial PR is regulated by a paracrine factor produced by uterine stroma [32, 42] . Insulin or molecules in extracellular matrix may modify epithelial PR expression directly on epithelium or indirectly via activation of stromal paracrine signals. This study has shown that mechanical stimulation can alter expression patterns of PR in endometrial stroma. For the organ-culture experiment, uterine horns were cut into small pieces by a sharp blade, and the mechanical force used during the preparation of uterine tissue may modify expression of PR in uterine organ culture.
The 5Ј-region of the PR gene contains clusters of ERE half-sites that are essential for transactivation of the PR gene by ligand-occupied ER [11] [12] [13] . However, the mouse PR gene is not a typical ERE-regulated gene, and its 5Ј-region contains many other putative binding sites for other regulatory transcription factors [56] . To our knowledge, it has not been reported if E 2 can activate PR gene transcription via ER␤, or if ICI can block the ER␤-mediated transcription of the PR gene. Whether ER␤ can mediate upregulation of PR in endometrial stroma is not clear, but ER␤ protein was detected in exactly the same ␣ERKO endometrial stromal cells induced by E 2 to up-regulate their PR. Thus, our findings suggest that up-regulation of PR by E 2 is mediated by ER␤ in the ␣ERKO uterus. However, even if E 2 can induce PR in endometrial stroma of ␣ERKO mice via ER␤, PR induction in endometrial stroma is not regulated solely by ER␤, because PR was also up-regulated by E 2 in endometrial stroma of ␤ERKO mice, which express ER␣. These data suggest that E 2 can up-regulate uterine stromal PR via both ER␣ and ER␤, and that the both ER␣ and ER␤ pathways can work independently.
Recently, Weihua et al. [57] reported that down-regulation of uterine epithelial PR induced by E 2 requires ER␤ in immature mice. Our data show that ER␤ is not required for E 2 -induced down-regulation of uterine epithelial PR in ovariectomized adult female mice. In uteri of immature mice, Weihua et al. demonstrated that levels of ER␣ and ER␤ mRNA were equivalent. In contrast, in adult mice, the level of uterine ER␣ mRNA vastly exceeds the level of ER␤ mRNA [20] . Given the substantial difference in ER␤ and ER␣ mRNA levels and the difference in the mode of PR regulation in these two studies, the role of ER␤ in the uterus may differ in immature versus adult mice. Another major difference between these two studies is the involvement of the ovary. In the study of Weihua et al., intact immature mice were treated with E 2 , whereas in our study, adult mice were ovariectomized 2 wk before hormone treatment to minimize or eliminate the effects of endogenous estrogen and progesterone. The ␤ERKO mice have defects in ovarian differentiation [27] ; thus, the profile of systemic hormone levels in ␤ERKO mice likely differs from that of ovariectomized adult wild-type mice. In this regard, it is worth noting that progesterone inhibits estrogen-induced down-regulation of uterine epithelial PR [42] . Thus, levels of P 4 in the immature ␤ERKO mice could affect the level of PR. In the present study, ovariectomy controlled levels of ovarian sex hormones, whereas in the immature mouse study, these hormones were not controlled. For years, the immature uterine model has been used interchangeably with the ovariectomized adult uterine model. This discussion shows, however, that these models may be significantly different.
Estrogen can induce PR expression in the forebrain of ␣ERKO mice [58] . In both forebrain and uterine stroma of ␣ERKO mice, PR is induced by E 2 through an ER␣-independent mechanism. On the other hand, PR expression in decidual cells is independent of both estrogens and ERs. Because a high level of PR expression always coincided with the decidual cell phenotype, PR expression appeared to be determined by the differentiation status (i.e., decidualization) of endometrial stroma. Uterine and vaginal epithelia are other examples in which PR expression patterns are determined through differentiation. Both the uterus and the upper part of the vagina develop from paramesonephric duct (i.e., Müllerian duct). In rat and mouse uterine epithelial cells, estrogen and ER␣ are not required for a high level of PR expression [32] . In contrast, in vaginal epithelial cells, a high level of PR is expressed only in the presence of ER␣ and estrogen [32] . In rodent uterine epithelial cells, in which PR expression is independent of estrogen and ER␣, transcription factors regulating the PR gene likely are totally different from transcription factors in rodent vaginal epithelial cells, in which PR expression is dependent on estrogen and ER␣. Likewise, the profile of transcription factors regulating PR expression in endometrial stromal cells must be vastly different before and after the decidualization.
Our finding that E 2 and ER action are not essential for endometrial stromal cells to differentiate into decidual cells agrees with those of the classic studies in which decidualization was induced artificially by P 4 and traumatization without E 2 [35] . This concept has been confirmed in a study on ␣ERKO mice by Paria et al. [37] . However, differentiation of decidual cells is only part of the implantation reaction. Requirement for ER actions must be assessed in terms of the various aspects of decidualization. Recently, Curtis et al. [38] concluded that E 2 is essential for decidualization in wild-type, but not in ␣ERKO, mice based on increases in uterine weight. An increase in uterine weight is only one aspect of decidualization, however, and is not necessarily linked directly to decidual differentiation of endometrial stromal cells. In both ␣ERKO and wild-type mice, decidual differentiation can be induced by P 4 and mechanical stimulation (E 2 is not required) [37] . The weight of the uterus is mainly determined by the water content, and the water content results from many complex physiological reactions (e.g., congestion, inflammation, etc.) involving many different cell types (e.g., endometrial cells, endothelial cells, smooth muscle cells, and lymphocytes) and factors (e.g., steroids, lymphokines, and growth factors). Because so many factors can be involved in regulation of uterine weight, how ER␣-mediated E 2 action synergizes with P 4 and traumatization to increase uterine weight is not clear.
Although the level was low, P 4 or mechanical stimulation alone could induce a detectable level of PR in endometrial stroma. This may explain why endometrial cells, in which PR levels are extremely low in the absence of E 2 , can respond to P 4 without E 2 priming.
Action of estrogenic compounds on lactoferrin expression independent of ER␣ has been reported [59] . Chlordecone and 4-hydroxyestradiol-E 2 up-regulate lactoferrin in ␣ERKO uterus [59] . However, the mechanism of lactoferrin induction appears to differ from up-regulation of PR, because in ␣ERKO mice, E 2 has no effect on lactoferrin whereas PR is up-regulated in endometrial stroma by E 2 . Also, ICI does not block the induction of lactoferrin by chlordecone and 4-hydroxyestradiol-E 2 , whereas ICI inhibited E 2 -induced up-regulation of PR in uterine stroma of ␣ERKO mice. Identification of the molecules that mediate estrogen action in the uterus of ␣ERKO mice is unclear, and it may involve both direct estrogen action and paracrine circuitry.
